One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Heterogeneity in the incidence of kidney replacement therapy across Europe: a benchmarking tool to improve clinical practiceÂ
Lucia Cordero, Alberto Ortiz
doi : 10.1093/ckj/sfae155
Clinical Kidney Journal, Volume 17, Issue 7, July 2024, sfae155
To the lighthouse: navigating nephrology through the world of social media
doi : 10.1093/ckj/sfae170
The time is now: CKJ adopts new policies for patient representation and for more sex-inclusive research
doi : 10.1093/ckj/sfae192
Proximal tubule hypertrophy and hyperfunction: a novel pathophysiological feature in disease states
doi : 10.1093/ckj/sfae195
Physical exercise in haemodialysis patients: which type of exercise is more convenient?
doi : 10.1093/ckj/sfae165
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome
doi : 10.1093/ckj/sfae125
Association between magnesium, erythropoietin resistance and mortality: the Japanese Dialysis Outcomes and Practice Patterns Study (J-DOPPS)
doi : 10.1093/ckj/sfae153
Dialysis nurse demand in Europe: an estimated prediction based on modelling
doi : 10.1093/ckj/sfae162
Association of deprivation and its individual domains on outcomes in people with chronic kidney disease
doi : 10.1093/ckj/sfae086
Managing cardiovascular risk factors in patients with chronic kidney disease: pharmacological and non-pharmacological interventions in the Copenhagen CKD Cohort
doi : 10.1093/ckj/sfae158
The impact of dialysate flow rate on haemodialysis adequacy: a systematic review and meta-analysis
doi : 10.1093/ckj/sfae163
The impact of mild and moderate COVID-19 infection on the progression of kidney dysfunction in patients with IgA nephropathy
doi : 10.1093/ckj/sfae157
Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort
doi : 10.1093/ckj/sfae131
Long-term clinicopathological characteristics of TAFRO syndrome and its relapse: a case series study
doi : 10.1093/ckj/sfae110
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis
doi : 10.1093/ckj/sfae142
Association of retinal age gap with chronic kidney disease and subsequent cardiovascular disease sequelae: a cross-sectional and longitudinal study from the UK Biobank
doi : 10.1093/ckj/sfae088
Diuretic prescriptions in the first year of haemodialysis: international practice patterns and associations with outcomes
doi : 10.1093/ckj/sfae141
Remote symptom monitoring with patient-reported outcome measures in outpatients with chronic kidney disease (PROKID): a multicentre randomised controlled non-inferiority study
doi : 10.1093/ckj/sfae176
Association between wet-bulb globe temperature and kidney function in different geographic regions in a large Taiwanese population study
doi : 10.1093/ckj/sfae173
Usefulness of the Clinical Frailty Scale in patients with end-stage kidney disease
doi : 10.1093/ckj/sfae132
The role of genomic disorders in chronic kidney failure of undetermined aetiology ≤50 years
doi : 10.1093/ckj/sfae166
Integrative profiling of untreated primary membranous nephropathy at the single-cell transcriptome level
doi : 10.1093/ckj/sfae168
Use of lung ultrasound to assess volume status and its association with physical examination in patients with chronic kidney disease
doi : 10.1093/ckj/sfae167
Long-term effect of increasing water intake on repeated self-assessed health-related quality of life (HRQoL) in autosomal dominant polycystic kidney disease
doi : 10.1093/ckj/sfae159
Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes
doi : 10.1093/ckj/sfae196
Impact of physical activity on surrogate markers of cardiovascular disease in the haemodialysis population
doi : 10.1093/ckj/sfae198
Risk factors of peritoneal dialysis–related peritonitis in the Japan Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)
doi : 10.1093/ckj/sfae202
Measures of wave intensity as a non-invasive surrogate for cardiac function predicts mortality in haemodialysis patients
doi : 10.1093/ckj/sfae172
Transfers from home to facility-based dialysis: comparisons of HHD, assisted PD and autonomous PD
doi : 10.1093/ckj/sfae094
Effects of ACE inhibitor/ARB therapy and long COVID on kidney disease: a retrospective cohort study using real-world data
doi : 10.1093/ckj/sfae164
Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease–mineral and bone disorder
doi : 10.1093/ckj/sfae188
Does COVID-19 vaccination trigger gross hematuria in patients with IgA nephropathy?
doi : 10.1093/ckj/sfae160
Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use
doi : 10.1093/ckj/sfae190
Nafamostat mesylate has advantages as an anticoagulant for patients undergoing maintenance hemodialysis with conjunctival bleeding
doi : 10.1093/ckj/sfae175
Assessment of SGLT2 inhibitors' safety and discontinuation causes in patients with advanced chronic kidney disease: insights from a real-world data analysis
doi : 10.1093/ckj/sfae169
Unexpected seronegative response in relapsed PLA2R-associated membranous nephropathy
doi : 10.1093/ckj/sfae189
